ALMKT:EPA
Mauna Kea Technologies SA
€ 0.090
arrow_upward
+1.13%(+0.00100) Siku 1
19 Nov, 17:35:01 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
17.22M
Wastani wa kiasi cha mauzo
elfu 472.14
Kiasi cha mauzo ya hisa
elfu 173.97
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.76
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
17.22M
Wastani wa kiasi cha mauzo
elfu 472.14
Kiasi cha mauzo ya hisa
elfu 173.97
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.76
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Harvard Law School Forum on Corporate Governance
·
saa 7 zilizopita
Board Practices and Composition in the Russell 3000 and S&P 500
The Motley Fool
·
dakika 57 zilizopita
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
Barron's
·
saa 7 zilizopita
S&P 500 Futures Rise in Premarket Trading; Credicorp, Intercorp Finl Svcs Lead
24/7 Wall St.
·
saa 2 zilizopita
S&P 500 Drops Nearly 1% at Midday While the Dow Slides 1.5%
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com